Skip to main content
SpringerLink
Log in

Acquired Demyelinating Diseases

  • Chapter
  • First Online:
Diseases of the Brain, Head and Neck, Spine 2016-2019

  • 2050 Accesses

Abstract

Demyelinating disorders of the central nervous system (CNS) have a variety of etiologies and can be separated into primary (e.g., multiple sclerosis (MS) and other idiopathic inflammatory-demyelinating diseases) and secondary (e.g., infectious, ischemic, metabolic, or toxic) diseases. Brain and spinal cord magnetic resonance imaging (MRI) is the imaging modality of choice to assess demyelinating disorders and, together with the clinical and laboratory findings, can accurately classify them in most cases [1–3]. This review will highlight the important imaging manifestations of some acquired demyelinating diseases that allow more specific diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith AB, Smirniotopoulos JG (2010) Imaging evaluation of demyelinating processes of the central nervous system. Postgrad Med J 86:218–229

    Article  PubMed  Google Scholar 

  2. Cañellas AR, Gols AR, Izquierdo JR et al (2007) Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology 49:393–409

    Article  PubMed  Google Scholar 

  3. Aliaga ES, Barkhof F (2014) MRI mimics of multiple sclerosis. Handb Clin Neurol 122:291–316

    Article  PubMed  Google Scholar 

  4. Rovira A, León A (2008) MR in the diagnosis and monitoring of multiple sclerosis: an overview. Eur J Radiol 67:409–414

    Article  PubMed  Google Scholar 

  5. Filippi M, Rocca MA (2011) MR imaging of multiple sclerosis. Radiology 259:659–681

    Article  PubMed  Google Scholar 

  6. Rovira À, Wattjes MP, Tintoré M et al (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol 11:471–482

    Article  PubMed  Google Scholar 

  7. Bagnato F, Jeffries N, Richert ND et al (2003) Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 126:1782–1789

    Article  PubMed  Google Scholar 

  8. Lycklama G, Thompson A, Filippi M et al (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2:555–562

    Article  PubMed  Google Scholar 

  9. Cotton F, Weiner HL, Jolesz FA et al (2003) MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60:640–646

    Article  PubMed  Google Scholar 

  10. Masdeu JC, Quinto C, Olivera C et al (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427–1433

    Article  CAS  PubMed  Google Scholar 

  11. Popescu BF, Lucchinetti CF (2012) Pathology of demyelinating diseases. Annu Rev Pathol 7:185–217

    Article  CAS  PubMed  Google Scholar 

  12. Mehler MF, Rabinowich L (1989) Inflammatory myelinoclastic diffuse sclerosis (Schilder’s disease): neuroradiologic findings. AJNR Am J Neuroradiol 10:176–180

    CAS  PubMed  Google Scholar 

  13. Hardy TA, Miller DH (2014) Baló’s concentric sclerosis. Lancet Neurol 13:740–746

    Article  PubMed  Google Scholar 

  14. Stadelmann C, Ludwin S, Tabira T et al (2005) Tissue preconditioning may explain concentric lesions in Baló’s type of multiple sclerosis. Brain 128:979–987

    Article  PubMed  Google Scholar 

  15. Trebst C, Jarius S, Berthele A et al (2014) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 261:1–16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112

    Article  CAS  PubMed  Google Scholar 

  17. Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489

    Article  CAS  PubMed  Google Scholar 

  18. Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189

    Article  PubMed  PubMed Central  Google Scholar 

  19. Yonezu T, Ito S, Mori M et al (2014) “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler 20:331–337

    Article  PubMed  Google Scholar 

  20. Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1165–1173

    Article  PubMed  PubMed Central  Google Scholar 

  21. Misu T, Fujihara K, Nakashima I et al (2005) Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 65:1479–1482

    Article  CAS  PubMed  Google Scholar 

  22. Krupp LB, Tardieu M, Amato MP et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19:1261–1267

    Article  PubMed  Google Scholar 

  23. Verhey LH, Branson HM, Shroff MM et al (2011) MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol 10:1065–1073

    Article  PubMed  Google Scholar 

  24. Tenembaum S, Chamoles N, Fejerman N (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59:1224–1231

    Article  PubMed  Google Scholar 

  25. Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9:425–437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wattjes MP, Barkhof F (2014) Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI. Curr Opin Neurol 27:260–270

    Article  CAS  PubMed  Google Scholar 

  27. Gottumukkala RV, Romero JM, Riascos RF et al (2014) Imaging of the brain in patients with human immunodeficiency virus infection. Top Magn Reson Imaging 23:275–291

    Article  PubMed  Google Scholar 

  28. Geibprasert S, Gallucci M, Krings T (2010) Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol 20:1492–1501

    Article  PubMed  Google Scholar 

  29. Rovira A, Alonso J, Cordoba J (2008) MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 29:1612–1621

    Article  CAS  PubMed  Google Scholar 

  30. Arbelaez A, Pajon A, Castillo M (2003) Acute Marchiafava-Bignami disease: MR findings in two patients. AJNR Am J Neuroradiol 24:1955–1957

    PubMed  Google Scholar 

  31. Gallucci M, Bozzao A, Splendiani A et al (1990) Wernicke encephalopathy: MR findings in five patients. AJR Am J Roentgenol 155:1309–1314

    Article  CAS  PubMed  Google Scholar 

  32. Zuccoli G, Santa Cruz D, Bertolini M et al (2009) MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 30:171–176

    Article  CAS  PubMed  Google Scholar 

  33. Ruzek KA, Campeau NG, Miller GM (2004) Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR Am J Neuroradiol 25:210–213

    PubMed  Google Scholar 

  34. Soussain C, Ricard D, Fike JR et al (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639–1651

    Article  CAS  PubMed  Google Scholar 

  35. Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487

    CAS  PubMed  Google Scholar 

  36. Rimkus Cde M, Andrade CS, Leite Cda C et al (2014) Toxic leukoencephalopathies, including drug, medication, environmental, and radiation-induced encephalopathic syndromes. Semin Ultrasound CT MR 35:97–117

    Article  PubMed  Google Scholar 

  37. Baehring JM, Fulbright RK (2008) Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry 79:535–539

    Article  CAS  PubMed  Google Scholar 

  38. Davis P, Hoffman JJ, Pearl G et al (1986) CT evaluation of effects of cranial radiation therapy in children. AJR Am J Roentgenol 147:587–592

    Article  CAS  PubMed  Google Scholar 

  39. Wijdicks EF, Campeau N, Sundt T (2008) Reversible unilateral brain edema presenting with major neurologic deficit after valve repair. Ann Thorac Surg 86:634–637

    Article  PubMed  Google Scholar 

  40. McKinney AM, Short J, Truwit CL et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189:904–912

    Article  PubMed  Google Scholar 

  41. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206

    CAS  PubMed  Google Scholar 

  42. Covarrubias D, Luetmer P, Campeau N (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23:1038–1048

    PubMed  Google Scholar 

  43. Post JD, Beauchamp NJ (1998) Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18:353–367

    Article  Google Scholar 

  44. Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E (2014) Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology 82:2127–2138

    Article  PubMed  Google Scholar 

  45. van dem Boom R, Lesnick Oberstein S et al (2006) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging changes and apolipoprotein E genotype. AJNR Am J Neuroradiol 27:359–362

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Neuroradiology and MR Unit (IDI), Department of Radiology, Hospital Universitari Vall d’Hebron, Autonomous University of Barcelona, Barcelona, Spain

    Àlex Rovira

  2. Section of Neuroradiology, Department of Radiology, Mayo Clinic, Rochester, MN, USA

    Kelly K. Koeller

Authors
  1. Àlex Rovira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelly K. Koeller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelly K. Koeller .

Editor information

Editors and Affiliations

  1. UniversitätsSpital Zürich, Zürich, Switzerland

    Jürg Hodler

  2. Zürich, Switzerland

    Rahel A. Kubik-Huch

  3. Klinik/Poliklinik Nuklearmedizin, Zürich, Switzerland

    Gustav K. von Schulthess

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rovira, À., Koeller, K.K. (2016). Acquired Demyelinating Diseases. In: Hodler, J., Kubik-Huch, R., von Schulthess, G. (eds) Diseases of the Brain, Head and Neck, Spine 2016-2019. Springer, Cham. https://doi.org/10.1007/978-3-319-30081-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30081-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30080-1

  • Online ISBN: 978-3-319-30081-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation